Coronial
TAShome

Coroner's Finding: Adams, Christopher Neil

Deceased

Christopher Neil Adams

Demographics

31y, male

Date of death

2017-02-28

Finding date

2020-05-19

Cause of death

mixed prescription drug toxicity (methadone, fluvoxamine, tramadol, mirtazapine and diazepam) and advanced heart disease

AI-generated summary

Christopher Neil Adams, 31, died from mixed prescription drug toxicity (methadone, fluvoxamine, tramadol, mirtazapine, diazepam) combined with advanced coronary atherosclerotic disease. He had a documented history of opioid addiction, multiple emergency presentations for medication overdose, and drug-seeking behaviour managed by his GP and pharmacy services. Despite safeguards (locked medication storage), he obtained all his medications before visiting his partner's home. He then illicitly acquired methadone from an unknown source—likely diverted from someone in the methadone program—and ingested it with other CNS depressants. With low tolerance to methadone, obesity, and severe heart disease, he died from respiratory depression and aspiration. The coroner emphasised that adherence to Tasmanian methadone prescribing guidelines (TOPP guidelines) is essential to prevent illegal diversion and community harm.

AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes.

Specialties

general practiceemergency medicineforensic medicineaddiction medicinecardiology

Error types

system

Drugs involved

methadonefluvoxaminetramadolmirtazapinediazepamibuprofenparacetamol/codeinediazepamamitriptylineoxycodone

Clinical conditions

opioid addictiondepressionanxietyinsomniaadvanced coronary atherosclerotic vascular diseaseleft ventricular hypertrophyobesityshoulder injuryback injuryrespiratory depressionaspiration

Contributing factors

  • illicit ingestion of methadone diverted from methadone program
  • low tolerance to methadone
  • multiple central nervous system depressants ingested concurrently
  • advanced coronary atherosclerotic vascular disease
  • obesity
  • aspiration of gastric content
  • history of opioid addiction and drug-seeking behaviour
  • inadequate safeguards against access to medications

Coroner's recommendations

  1. Medical practitioners and pharmacists should adhere strictly to the Tasmanian Opioid Pharmacotherapy Program Policy and Clinical Practice Standards (TOPP guidelines) regarding take-away dose prescribing
  2. Take-away doses should be exceptional, with patients consuming daily doses under close supervision of accredited pharmacists
  3. Deviation from TOPP guidelines requires documented clinical risk-benefit assessment and input from Alcohol and Drug Services
  4. Doctors or pharmacists requiring information about appropriate prescribing of take-away methadone doses should contact Alcohol and Drug Services
Full text
Official source Archived copy

Related cases

Source and disclaimer

This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.

Content may be incomplete, reformatted, or summarised. All court orders for redaction and non-publication are respected; documents with technically defective redaction have been excluded from the database entirely. Always refer to the original court publication for the authoritative record.

Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction —